The 4 references without contexts in paper G. Vasilenko F., N. Dubovik S., I. Shohin E., G. Gildeeva N., G. Ramenskaya V., L. Pavlova A., Г. Василенко Ф., Н. Дубовик С., И. Шохин Е., Г. Гильдеева Н., Г. Раменская В., Л. Павлова А. (2018) “Оценка влияния автоматизации на вариабельность результатов теста «Растворение» на примере лекарственного препарата «Бетагистина гидрохлорид таблетки 16 мг» // Assessing the impact of the automation on the variability of the «Dissolution» test results as exemplified by «Betahistine hydrochloride tablets 16 mg»” / spz:neicon:vedomostincesmp:y:2016:i:3:p:53-57

3
Zhang Hua Yu, Lawrence X. Dissolution testing for solid oral drug products: theoretical considerations. Amer Pharm Rev. 2010; (6): 1–4.
(check this in PDF content)
4
Smehova IE, Perova YuM, Kondratiev IA, Rodygina AN, Turetskova NN. Test «Dissolution» and modern approaches to the assessment of equivalence of drugs. Razrabotka i registratsiya lekarstvennyh sredstv 2013;1(2): 50–60 (in Russian).
(check this in PDF content)
6
Iarriccio A, Kassis A, Patel T. Increasing the Efficiency of the Dissolution Laboratory through Automation. The Review of American Pharmaceutical Business and Technology 2011.
(check this in PDF content)
7
Kretz J, Wong-Moon K. Evaluation of Automation to Increase Efficiency in the Dissolution Lab. Dissolution Technologies 2013; 20(2): 33–7.
(check this in PDF content)